CALCIMEDICA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.2 USD | -7.14% |
|
-7.80% | +81.81% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 16.26 | 55.85 | - | - |
| Enterprise Value (EV) 1 | 16.26 | 55.85 | 55.85 | 55.85 |
| P/E ratio | -0.37 x | -2.27 x | -2.36 x | -2.95 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | 19.9 x |
| EV / Revenue | - | - | - | 19.9 x |
| EV / EBITDA | -0.43 x | -2.15 x | -1.77 x | -1.76 x |
| EV / FCF | - | -1.8 x | -1.6 x | -1.3 x |
| FCF Yield | - | -55.5% | -62.7% | -77% |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 5,685 | 10,740 | - | - |
| Reference price 2 | 2.860 | 5.200 | 5.200 | 5.200 |
| Announcement Date | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | 2.8 |
| EBITDA 1 | - | - | -38.02 | -26 | -31.5 | -31.7 |
| EBIT 1 | - | - | -38.08 | -26.4 | -36.17 | -34.35 |
| Operating Margin | - | - | - | - | - | -1,226.79% |
| Earnings before Tax (EBT) 1 | - | - | -34.36 | -26 | -35.8 | -34.15 |
| Net income 1 | -23.5 | -14.51 | -34.36 | -26 | -35.8 | -34.15 |
| Net margin | - | - | - | - | - | -1,219.64% |
| EPS 2 | -8.650 | -5.080 | -7.660 | -2.290 | -2.203 | -1.760 |
| Free Cash Flow 1 | - | - | - | -31 | -35 | -43 |
| FCF margin | - | - | - | - | - | -1,535.71% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 1/20/23 | 4/4/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - |
| EBITDA 1 | - | - | - | -4.3 | -5.752 | -5.9 | -6.8 | -8.3 |
| EBIT 1 | -22.34 | -6.583 | -4.833 | -4.319 | -5.767 | -7.1 | -5.75 | -6.35 |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -19.29 | -6.304 | -4.619 | -4.146 | 0.13 | -6.333 | -6.1 | -6.967 |
| Net income 1 | -19.29 | -6.304 | -4.619 | -4.146 | 0.13 | -6.333 | -6.1 | -6.967 |
| Net margin | - | - | - | - | - | - | - | - |
| EPS 2 | -3.407 | -1.110 | -0.8200 | -0.2300 | 0.0100 | -0.5967 | -0.5133 | -0.5100 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 5/12/23 | 8/10/23 | 11/9/23 | 3/28/24 | 5/13/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | -31 | -35 | -43 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 1/20/23 | 4/4/23 | 3/28/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.2
USD
Average target price
18.67
USD
Spread / Average Target
+258.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +81.81% | 55.85M | |
| +4.15% | 111B | |
| +11.52% | 105B | |
| -12.94% | 22.34B | |
| -3.70% | 21.93B | |
| -6.03% | 18.59B | |
| -35.21% | 18.12B | |
| -10.19% | 16.96B | |
| +3.34% | 13.7B | |
| +37.41% | 12.45B |
- Stock Market
- Equities
- CALC Stock
- Financials CalciMedica, Inc.